standard
definit
differ
area
world
lack
largescal
studi
base
signific
cohort
permit
epidemiolog
certainti
estim
epidemiolog
sepsi
publish
reli
mostli
discharg
diagnosi
data
annual
incid
high
unit
state
around
per
popul
mortal
also
high
morbid
mortal
depend
characterist
host
infect
microb
term
incid
mortal
situat
regard
sepsi
sever
sepsi
area
latin
america
africa
asia
may
wors
develop
countri
although
averag
age
patient
diagnosi
sepsi
time
discharg
year
attack
rate
high
children
case
per
popul
per
year
lowweight
newborn
highest
incid
incid
mortal
decreas
age
year
increas
gradual
adulthood
infect
origin
lung
abdomen
urinari
tract
skin
studi
ventilatorassoci
pneumonia
lead
caus
death
hospitalacquir
infect
icu
set
bacterem
patient
frequent
evolv
develop
sepsi
sever
sepsi
septic
shock
correspondingli
increas
mortal
adult
unit
state
europ
around
patient
admit
icu
diagnosi
sepsi
alreadi
hospit
caus
come
hospit
ward
sever
bacteremia
sepsi
caus
classic
pathogen
neisseria
meningitidi
streptococcu
pyogen
rare
found
replac
sepsi
caus
commens
microb
infect
individu
condit
compromis
skin
mucos
barrier
immun
system
advanc
surgic
techniqu
includ
transplant
medicin
increas
surviv
patient
trauma
splenectomi
neutropenia
part
caus
advanc
treatment
sepsi
associ
condit
patient
respons
microorgan
isol
organ
isol
blood
infect
site
one
usual
caus
infect
healthi
person
frequent
infect
polymicrobi
although
mani
year
gramneg
bacteria
found
bacterem
patient
sever
sepsi
percentag
case
associ
blood
isol
gramposit
pathogen
increas
last
decad
staphylococcu
aureu
coagulaseneg
staphylococci
enterococci
respons
case
anoth
recent
tendenc
isol
fungi
notabl
speci
candida
difficulttotreat
pathogen
includ
pseudomona
aeruginosa
acinetobact
speci
klebsiella
pneumonia
enterobact
speci
resist
enterococci
methicillinresist
aureu
new
syndrom
sever
necrot
pneumonia
produc
infect
communityacquir
methicillinresist
aureu
led
icu
admiss
sever
manifest
organ
also
consid
hospit
pathogen
cumul
econom
impact
resist
bacteria
enorm
candidemia
commonli
origin
cathet
colon
patient
speci
candida
resist
antifung
spread
hematogen
seed
lung
liver
spleen
cardiac
structur
bone
skin
eye
mortal
substanti
introduct
new
class
antibiot
antifung
oxazolidinon
glycylglycin
equinocandin
improv
abil
treat
resist
pathogen
malaria
continu
repres
lead
caus
diseas
burden
term
death
disabl
substanti
part
world
world
popul
live
countri
africa
asia
central
america
oceania
south
america
diseas
endem
global
million
malariarel
death
occur
annual
children
worst
affect
group
especi
children
age
month
year
may
caus
mani
death
children
endem
region
subsaharan
africa
addit
almost
everi
countri
world
experi
import
malaria
approxim
case
death
caus
malaria
diagnos
everi
year
unit
state
acquir
outsid
countri
half
case
origin
africa
plasmodia
metabol
hemoglobin
red
blood
cell
protein
creat
toxic
pigment
call
hemozoin
parasit
deriv
energi
sole
glucos
metabol
time
faster
red
blood
cell
inhabit
hypoglycemia
lactic
acidosi
common
find
anemia
caus
lysi
infect
uninfect
red
blood
cell
suppress
hematopoiesi
increas
clearanc
red
blood
cell
spleen
time
malaria
infect
may
induc
thrombocytopenia
hepatosplenomegali
four
speci
plasmodium
known
infect
man
p
falciparum
import
parasit
capabl
infect
red
cell
age
caus
heavi
parasit
load
also
induc
product
proteinac
knob
bind
endotheli
cell
cytoadher
infect
red
blood
cell
tend
clump
togeth
within
small
blood
vessel
mani
organ
tissu
account
much
damag
incur
parasit
larg
degre
damag
observ
malaria
p
falciparum
seem
relat
damag
inflict
host
respons
parasit
thought
relat
releas
tumor
necrosi
factor
upregul
tumor
necrosi
factor
receptor
type
consequ
express
adhes
molecul
intercellular
adhes
molecul
especi
infect
cell
stick
endothelium
use
larg
malari
protein
call
bind
thrombospondin
p
falciparum
malaria
potenti
lifethreaten
diseas
close
clinic
laboratori
monitor
patient
necessari
moreov
reliabl
criteria
icu
admiss
defin
risk
factor
identifi
box
children
complic
sever
malaria
includ
metabol
acidosi
often
caus
hypovolemia
hypoglycemia
lactic
acidosi
sever
anemia
seizur
increas
intracrani
pressur
adult
renal
failur
pulmonari
edema
common
caus
death
contrast
concomit
bacteri
infect
occur
frequent
children
associ
mortal
admiss
critic
care
unit
icu
may
help
reduc
mortal
frequenc
sever
sequela
relat
sever
malaria
mortal
acut
renal
failur
without
dialysi
earli
diagnosi
establish
renal
failur
institut
dialysi
import
prevent
mortal
rapidli
rise
creatinin
level
sensit
indic
need
dialysi
periton
dialysi
reduc
mortal
hemofiltr
even
effect
associ
improv
outcom
earli
icu
monitor
attempt
especi
follow
condit
lack
clinic
respons
antimalari
treatment
within
hour
sign
neurolog
disturb
hypoglycemia
exclud
prospect
multicent
trial
guidelin
support
intens
care
urgent
need
mortal
reduc
earli
recognit
featur
sever
malaria
prompt
administr
appropri
antimalari
treatment
complic
prefer
icu
set
clinician
must
high
index
suspicion
especi
travel
recent
visit
endem
area
high
standard
nurs
care
continu
observ
acut
stage
diseas
import
reduc
mortal
leptospirosi
widespread
infect
transmit
among
anim
occasion
anim
human
direct
exposur
urin
infect
anim
urinecontamin
water
soil
recreat
occup
activ
repres
main
sourc
infect
human
gener
occup
greater
risk
includ
dairi
farmer
sewer
worker
soldier
common
sourc
exposur
develop
countri
dog
household
pet
follow
livestock
rodent
wild
anim
although
distribut
leptospirosi
worldwid
tropic
region
bear
brunt
impact
moreov
environment
condit
preval
tropic
subtrop
region
includ
abund
rainfal
nonacid
soil
high
temperatur
along
numer
natur
water
cours
abund
biodivers
particularli
favor
transmiss
leptospira
infect
icter
form
weil
syndrom
associ
sever
hepat
malfunct
mark
jaundic
hemorrhag
cardiac
hemodynam
pulmonari
neurolog
alter
weil
syndrom
high
mortal
rate
frequent
serum
bilirubin
level
mg
per
cm
although
hepat
malfunct
major
caus
death
associ
higher
incid
complic
higher
mortal
renal
involv
sever
leptospirosi
character
increas
urea
creatinin
level
elev
sodium
excret
fraction
nonspecif
abnorm
find
urinalysi
includ
leukocyturia
hematuria
proteinuria
crystalluria
oliguria
occur
variabl
frequenc
acut
renal
failur
may
aggrav
hemodynam
alter
dehydr
arteri
hypotens
notabl
metabol
acidosi
occur
frequent
oligur
patient
use
dialysi
method
manag
acut
renal
failur
highli
improv
surviv
patient
sever
leptospirosi
clinic
cardiac
involv
frequent
consequ
concurr
myocard
metabol
disturb
hypokalemia
may
aggrav
condit
common
manifest
ekg
alter
cardiac
arrhythmia
hemorrhag
phenomena
rel
common
may
occur
skin
mucosa
intern
organ
past
decad
pulmonari
hemorrhag
increasingli
recogn
throughout
world
grave
manifest
leptospirosi
pulmonari
hemorrhag
may
vari
ordinari
hemopto
sputum
massiv
pulmonari
hemorrhag
gastrointestin
hemorrhag
variabl
degre
sever
may
also
occur
manifest
melena
hematemesi
enterorrhagia
pulmonari
involv
character
presenc
hemorrhag
interstiti
pneumonia
diffus
local
pulmonari
infiltr
respiratori
failur
decreas
arteri
pao
attribut
impair
oxygen
diffus
alveolarcapillari
membran
level
result
edema
blood
leakag
pulmonari
interstitium
leptospirosi
associ
high
lethal
complic
organ
dysfunct
poor
prognost
factor
male
gender
alcohol
depend
age
year
high
multipl
organ
dysfunct
score
acut
respiratori
distress
syndrom
presenc
metabol
acidosi
need
mechan
ventil
time
intervent
intens
therapi
howev
may
lifesav
excess
morbid
mortal
associ
influenza
epidem
increas
hospit
cost
secondari
sever
case
diseas
primari
influenza
pneumonia
secondari
bacteri
pneumonia
mix
viral
bacteri
pneumonia
critic
human
featur
influenza
viru
infect
although
children
among
group
risk
develop
influenza
complic
like
spread
infect
other
complic
season
influenza
occur
frequent
among
patient
older
year
chronic
comorbid
includ
diseas
cardiovascular
pulmonari
system
diabet
mellitu
hemoglobinopathi
renal
insuffici
immunosuppress
pregnanc
may
also
pose
ad
risk
recent
inform
suggest
least
avian
influenza
virus
may
caus
lifethreaten
lethal
diseas
individu
without
predispos
factor
differ
neuraminidas
viral
featur
might
make
pathogen
human
unknown
despit
fact
influenza
gener
worldwid
distribut
tend
occur
partial
confin
outbreak
commun
vari
size
preval
one
viral
strain
primari
influenza
pneumonia
commonli
caus
influenza
viru
common
reliabl
inform
exist
exact
preval
complic
diseas
estim
vari
studi
sequenti
epidem
suggest
overal
complic
rate
close
complic
respiratori
influenza
begin
abruptli
typic
featur
season
diseas
progress
rapidli
relentlessli
adult
respiratori
distress
syndrom
diagnosi
may
made
aid
epidemiolog
rapid
test
viral
isol
cultur
polymeras
chain
reaction
serolog
clinic
practic
seldom
document
time
effect
therapeut
measur
taken
sputum
bacteriolog
help
chest
radiographi
typic
show
bilater
infiltr
without
consolid
local
pneumonia
segment
unilater
infiltr
occur
respons
antibiot
treatment
mortal
high
patholog
show
diffus
pneumonia
hemorrhag
hyalin
membran
littl
inflamm
ion
channel
inhibitor
amantadin
rimantadin
activ
strain
influenza
b
c
virus
activ
current
viru
strain
threaten
becom
precursor
next
pandem
neuraminidas
inhibitor
extrem
activ
influenza
strain
remain
activ
influenza
b
strain
avian
virus
neuraminidas
subtyp
resist
strain
describ
clinic
inform
support
efficaci
antivir
drug
sever
influenza
pneumonia
avail
recommend
made
base
case
report
secondari
bacteri
pneumonia
usual
suspect
patient
experi
exacerb
fever
respiratori
symptom
period
improv
influenza
likeil
biphas
evolut
may
present
bacteri
pneumonia
may
coincid
viral
pneumonia
mix
viral
bacteri
pneumonia
may
also
clinic
indistinguish
pneumonia
absenc
viral
infect
separ
difficult
influenza
outbreak
streptococcu
pneumonia
haemophilu
influenza
aureu
mycoplasma
pneumonia
pathogen
respons
sever
acut
respiratori
syndrom
seriou
infecti
pulmonari
ill
jump
speci
semidomest
anim
human
spread
china
hong
kong
late
affect
individu
care
china
hong
kong
case
treat
countri
includ
vietnam
singapor
thailand
taiwan
canada
intens
care
set
approxim
month
first
case
coronaviru
identifi
caus
organ
sever
acut
respiratori
syndrom
main
symptom
includ
high
fever
myalgia
cough
dyspnea
progress
adult
respiratori
distress
syndrom
multipl
organ
dysfunct
reversetranscriptas
polymeras
chain
reaction
serolog
cultur
possibl
shortcom
make
routin
clinic
use
difficult
specif
anticoronaviru
therapi
support
care
remain
princip
therapeut
altern
rivabirin
corticosteroid
use
efficaci
establish
mortal
around
infect
control
practic
extrem
import
halt
progress
outbreak
gener
tetanu
proteintoxin
mediat
neurolog
disord
caus
clostridium
tetani
oblig
anaerob
motil
gramposit
rod
termin
spore
tradit
continu
repres
despit
effect
vaccin
common
caus
intens
care
admiss
long
associ
high
mortal
cost
global
incid
tetanu
estim
million
case
per
year
unit
state
report
case
death
tetanu
decreas
substanti
sinc
success
vaccin
effort
risk
develop
clinic
tetanu
acut
punctur
lacer
higher
patient
older
year
reflect
wane
immun
signific
proport
case
occur
women
low
mortal
rate
inject
drug
user
grow
popul
risk
sharp
contrast
epidemiolog
gener
tetanu
develop
countri
mortal
figur
may
time
higher
follow
close
problem
lack
immun
effort
area
neonat
tetanu
occur
offspr
unvaccin
women
caus
approxim
case
mortal
even
wors
mother
past
histori
babi
suffer
neonat
tetanu
account
one
third
case
one
studi
diseas
seen
predominantli
rural
area
area
soil
cultiv
tropic
region
summer
month
templat
region
develop
countri
neonat
tetanu
must
still
suspect
especi
popul
avoid
standard
vaccin
prenat
care
tetanu
one
diseas
diagnos
clinic
ground
major
differenti
diagnosi
strychnin
poison
difficult
case
electromyographi
may
assist
clinician
treatment
detail
beyond
scope
articl
includ
support
therapi
attent
sever
clinic
manifest
passiv
immun
role
antibiot
c
tetani
remain
controversi
mortal
even
experienc
icu
may
reach
sever
case
tetanu
inexcus
diseas
prevent
threedos
seri
inexpens
safe
toxoid
expand
program
immun
reinforc
whatev
area
world
age
group
although
toxin
produc
clostridium
botulinum
structur
function
similar
c
tetani
clinic
effect
entir
differ
sens
opposit
wherea
tetanu
toxin
produc
muscular
rigid
spasm
botulinum
toxin
produc
muscl
weak
human
botul
also
worldwid
distribut
foodborn
diseas
usual
present
outbreak
epidemiolog
differ
tetanu
least
unit
state
parallel
presenc
toxin
type
present
spore
environ
countri
societi
around
world
alaska
china
egypt
mozambiqu
botul
may
link
food
prepar
techniqu
other
religi
practic
infant
botul
acquir
consumpt
spore
rather
toxin
commonli
attribut
consumpt
honey
sourc
may
present
constip
feed
problem
hypotonia
weak
cri
respiratori
assist
necessari
upper
airway
obstruct
ensu
commonli
follow
respiratori
insuffici
long
durat
relaps
describ
clinic
shortli
toxin
ingest
adult
patient
remain
mental
intact
develop
symmetr
descend
weak
acut
absenc
fever
sensori
deficit
outsid
eye
nausea
dri
mouth
diarrhea
may
accompani
neuropathi
sever
autonom
problem
may
also
present
patient
requir
mechan
ventil
may
necessit
long
period
treatment
icu
set
prolong
intub
toxin
type
may
predict
clinic
manifest
diseas
caus
toxin
tend
sever
diseas
caus
toxin
b
diagnosi
must
suspect
clinic
easier
outbreak
edrophonium
test
help
exclud
myasthenia
gravi
absenc
tick
attach
help
rule
tick
paralysi
yndrome
miller
fisher
variant
eatonlambert
myasthen
syndrom
acut
poliomyel
magnesium
intox
usual
differenti
diagnosi
anaerob
cultur
botul
toxin
assay
serum
intestin
content
suspect
foodstuff
use
avail
electromyograph
studi
especi
pain
repetit
nerv
stimul
treatment
consist
support
care
includ
ventil
assist
antitoxin
treatment
human
botul
immun
globulin
infant
botul
surgic
cleans
wound
lax
import
elimin
activ
lumin
toxin
patient
recoveri
slow
muscular
weak
neuropsychiatr
sequela
may
remain
applic
aspect
correct
food
handl
protocol
remain
best
prophylact
measur
botul
effect
vaccin
widespread
use
sore
need
epidemiolog
human
rabi
close
follow
anim
rabi
partial
understood
degre
develop
nation
may
predict
local
transmiss
pattern
gener
area
dog
immun
canin
rabi
exist
human
case
result
dog
bite
contrast
area
success
immun
program
human
case
deriv
exposur
wild
anim
speci
global
rabi
viru
broad
host
rang
dog
account
anim
rabi
major
reservoir
terrestri
mammal
bat
although
canin
rabi
rare
latin
america
remain
uncontrol
area
africa
asia
wild
anim
mongoos
africa
asia
skunk
gray
red
fox
raccoon
princip
reservoir
unit
state
coyot
jackal
america
europ
africa
asia
reservoir
ninetynin
countri
report
anim
rabi
report
case
unit
state
domest
anim
caus
case
human
cat
follow
dog
cattl
equin
sheep
goat
pig
also
transmit
rabi
variant
wide
varieti
speci
insectivor
bat
rabi
occur
north
america
europ
africa
asia
australia
histori
bite
obtain
substanti
proport
batassoci
human
rabi
worldwid
mani
individu
die
yearli
million
receiv
postexposur
prophylaxi
dose
vaccin
use
postexposur
prophylaxi
carri
risk
neurolog
advers
effect
rabi
viru
transmit
salivari
secret
contact
usual
bite
infect
anim
variabl
incub
period
viru
replic
local
later
reach
entri
central
nervou
system
centripet
motion
peripher
nerv
caus
enceph
lead
almost
invari
lethal
progress
neurolog
diseas
character
agit
upper
neuron
motor
paralysi
impair
respons
extern
signal
abnorm
neurolog
sign
infect
salivari
gland
possibl
tissu
clinic
stage
lead
shed
rabi
virion
potenti
transmiss
corneal
organ
transplant
respons
rare
humantohuman
transmiss
find
rabi
viru
antibodi
cerebrospin
fluid
patient
enceph
diagnost
rabi
reversetranscriptas
polymeras
chain
reaction
saliva
skin
biopsi
sampl
neck
high
sensit
detect
genet
rabi
viru
materi
brain
tissu
use
postmortem
definit
diagnosi
clinic
rabi
develop
specif
treatment
despit
optim
intens
care
almost
patient
gradual
die
even
intens
ventilatori
support
appli
mani
complic
develop
surviv
without
use
rabi
vaccin
girl
clinic
rabi
develop
month
bitten
bat
made
news
june
treat
induct
coma
support
icu
environ
receiv
ketamin
midazolam
ribavirin
amantadin
patient
discharg
day
hospit
care
month
exhibit
choreoathetosi
dysarthria
unsteadi
gait
treatment
protocol
modifi
specif
complic
appli
least
two
rabi
patient
surviv
achiev
preexposur
vaccin
highrisk
individu
strongli
recommend
postexposur
prophylaxi
effect
constitut
specif
measur
acut
bacteri
mening
remain
import
caus
morbid
mortal
neurolog
sequela
world
given
problem
report
unlik
world
preval
diseas
less
best
unit
state
estim
approxim
case
per
popul
per
year
area
brazil
attack
rate
might
high
case
per
popul
per
year
mening
epidem
strong
environment
compon
africa
sever
epidem
occur
sahelian
region
known
mening
belt
mortal
vari
estim
countri
h
influenza
vaccin
coverag
children
approach
develop
societi
three
major
epidemiolog
chang
occur
regard
communityacquir
bacteri
mening
dramat
decreas
mening
caus
h
influenza
bacteri
mening
becom
diseas
adult
pneumonia
lead
caus
mening
penicillin
resist
may
high
bacteri
pathogen
respons
n
meningitidi
group
b
streptococci
listeria
monocytogen
nosocomi
bacteri
mening
also
major
problem
case
fatal
ratio
approxim
case
fatal
rate
mening
caus
enterobacteriacea
much
higher
approach
factor
involv
pathogenesi
mening
includ
abil
colon
mucos
surfac
intravascular
surviv
mening
invas
surviv
subarachnoid
space
replic
establish
mening
tissu
alter
bloodbrain
barrier
increas
intracrani
pressur
alter
cerebr
blood
flow
neuron
injuri
develop
sever
neurolog
damag
mortal
host
consequ
patient
present
headach
fever
nuchal
rigid
sign
cerebr
dysfunct
kernig
brudzinski
sign
might
present
physic
examin
prompt
analysi
cerebrospin
fluid
includ
cultur
blood
cultur
typic
confirm
clinic
diagnosi
guid
empir
therapi
gram
stain
cultur
posit
case
dexamethason
plu
age
immun
statusdepend
bactericid
empir
specif
antimicrobi
therapi
penetr
cerebrospin
fluid
must
start
appropri
dose
immedi
patient
increas
intracrani
pressur
sever
method
avail
intensivist
effect
reduc
pressur
time
use
pneumococc
meningococc
h
influenza
vaccin
advoc
viral
hemorrhag
fever
heterogen
group
sever
lifethreaten
viral
diseas
common
base
degre
vascular
instabl
permeabl
decreas
vascular
integr
result
bleed
thrombocytopenia
may
featur
aggrav
bleed
tendenc
except
dengu
possibl
yellow
fever
travel
rural
area
frequent
epidemiolog
clue
diagnosi
diseas
mention
occur
threaten
occur
natur
briefli
highlight
epidemiolog
featur
might
make
intens
care
specialist
come
contact
dengu
fever
dengu
hemorrhag
fever
dhf
increasingli
import
public
health
problem
tropic
subtrop
dengu
call
import
mosquitotransmit
viral
diseas
term
morbid
mortal
billion
peopl
live
area
dengu
endem
diseas
found
countri
throughout
america
africa
eastern
mediterranean
southeast
asia
western
pacif
estim
million
case
dengu
fever
case
dhf
offici
notifi
annual
howev
true
incid
known
case
fatal
rate
vari
asian
countri
america
small
proport
case
viru
caus
increas
vascular
permeabl
lead
bleed
diathesi
dissemin
intravascular
coagul
characterist
dhf
secondari
infect
differ
dengu
viru
serotyp
confirm
import
risk
factor
develop
dhf
dhf
case
patient
develop
shock
known
dengu
shock
syndrom
worldwid
children
younger
year
compris
dhf
subject
howev
america
dhf
occur
adult
children
patient
dhf
develop
sign
dehydr
tachycardia
prolong
capillari
refil
time
cool
blotchi
skin
diminish
puls
amplitud
alter
mental
statu
decreas
urin
output
rise
hematocrit
narrow
puls
pressur
hypotens
requir
admiss
intraven
fluid
administr
patient
shock
may
classifi
one
two
group
accord
puls
pressur
admiss
puls
pressur
mm
hg
consid
moder
sever
wherea
patient
puls
pressur
mm
hg
consid
sever
shock
follow
type
patient
risk
attend
staff
must
particularli
alert
young
infant
year
old
dhf
grade
iv
prolong
shock
overweight
patient
patient
massiv
bleed
patient
chang
conscious
encephalopathi
patient
underli
diseas
eg
thalassemia
defici
congenit
heart
diseas
forth
refer
patient
patient
need
special
laboratori
investig
may
complic
intern
bleed
sever
hypoglycemia
electrolyt
imbal
hyponatremia
hypocalcemia
metabol
acidosi
liver
failur
renal
failur
assess
patient
condit
follow
laboratori
test
consid
essenti
hematocrit
blood
gase
serum
electrolyt
studi
liver
function
test
platelet
count
prothrombin
thrombin
time
partial
thromboplastin
time
dengu
shock
syndrom
medic
emerg
must
dealt
promptli
administ
intraven
fluid
increas
plasma
volum
patient
particularli
children
may
emerg
shock
period
patient
must
monitor
around
clock
medic
staff
blood
pressur
puls
respir
must
record
everi
minut
frequent
requir
shock
overcom
hematocrit
hemoglobin
level
check
everi
hour
first
hour
everi
hour
stabl
fluid
balanc
sheet
must
maintain
contain
detail
type
fluid
rate
volum
administr
volum
frequenc
urin
output
must
also
record
children
dengu
shock
syndrom
respond
well
cautiou
treatment
isoton
crystalloid
solut
earli
intervent
colloid
solut
gener
indic
fluid
regimen
ringer
lactat
mlkg
period
hour
support
strong
prospect
evid
recommend
children
moder
sever
shock
sever
shock
situat
less
straightforward
clinician
must
continu
reli
person
experi
local
avail
particular
product
cost
minor
advantag
initi
recoveri
observ
starch
significantli
advers
reaction
associ
dextran
use
colloid
consid
necessari
starch
may
prefer
option
yellow
fever
follow
differ
transmiss
pattern
area
subsaharan
africa
south
america
africa
epidemiolog
yellow
fever
outbreak
epidem
natur
studi
estim
epidem
last
two
decad
larg
south
america
sharp
contrast
lowgrad
endem
situat
exist
case
report
per
year
usual
young
men
rural
forest
area
jungl
cycl
potenti
urban
migrat
infect
individu
citi
largescal
epidem
caus
presenc
vector
citi
area
world
exist
yellow
fever
vari
greatli
clinic
present
sever
asymptomat
infect
undifferenti
febril
ill
typic
biphas
infect
plu
intox
ill
sever
hemorrhag
fever
high
mortal
abrupt
onset
fever
headach
myalgia
hepat
accompani
leucopenia
albuminuria
typic
may
present
patient
prostrat
common
sever
diseas
may
progress
stupor
coma
patient
must
treat
intens
care
facil
isol
mosquito
hypotens
shock
renal
failur
metabol
acidosi
poor
prognost
sign
sever
yellow
fever
seriou
diseas
case
fatal
ratio
secondari
bacteri
infect
worsen
prognosi
mani
patient
amen
treatment
laboratori
confirm
yellow
fever
serolog
tissu
sampl
import
epidemiolog
must
pursu
support
measur
use
need
treatment
protocol
affect
antivir
drug
develop
surviv
associ
lifelong
immun
arenaviru
lassa
viru
caus
endem
epidem
diseas
nigeria
sierra
leon
guinea
liberia
possibl
area
west
africa
viru
reach
human
endem
year
round
epidem
dri
season
rodent
aerosol
small
particl
also
transmit
close
interhuman
contact
nosocomi
exposur
number
case
africa
unknown
endem
countri
lassa
fever
common
caus
admiss
estim
place
ten
thousand
case
annual
africa
febril
diseas
contrast
dengu
fever
gradual
onset
follow
sever
fatigu
prostrat
maculopapular
rash
might
present
note
bleed
seen
case
elev
transaminas
level
predict
advers
outcom
consid
indic
ribavirin
treatment
convalesc
slow
associ
bilater
deaf
signific
number
case
progress
made
toward
vaccin
diseas
seen
rural
area
south
america
caus
junin
machupo
sabia
guanarito
arenavirus
far
local
public
health
problem
clinic
similar
lassa
fever
thrombocytopenia
central
nervou
system
dysfunct
common
sever
intens
care
specialist
outsid
area
unlik
see
patient
suspect
diagnosi
south
american
hemorrhag
fever
given
right
epidemiolog
exposur
except
sabia
viru
occur
contact
wild
rodent
rural
agricultur
area
hantaviru
pulmonari
syndrom
diseas
predomin
south
and
viru
north
america
sin
nombr
viru
china
russia
seoul
viru
laboratori
rat
may
infect
transmit
diseas
human
hantaviru
epidem
associ
season
year
increas
rodent
popul
virus
basic
parasit
wild
rodent
produc
sever
pulmonari
edema
secondari
increas
vascular
permeabl
hemoconcentr
shock
human
diseas
commonli
start
sever
myalgia
abdomin
pain
sever
hypoxia
shock
manag
icu
patient
surviv
revers
vascular
leak
permit
complet
recoveri
diagnosi
base
fact
igm
igg
antibodi
present
earli
ill
measur
elisa
admiss
reversetranscriptas
polymeras
chain
reaction
blood
sampl
immunohistochem
stain
tissu
may
detect
hantaviru
treatment
consist
judici
administr
fluid
cardioton
drug
support
measur
viral
hemorrhag
fever
interest
unlik
treat
icu
outsid
discret
area
world
crimeancongo
fever
ebola
marburg
viru
hemorrhag
fever
kyasanur
omsk
laboratori
confirm
import
approxim
patient
develop
symptom
acut
hepat
without
preexist
liver
diseas
progress
sever
acut
socal
fulmin
liver
failur
flf
hepat
failur
defin
presenc
encephalopathi
within
week
onset
symptom
term
acut
liver
failur
use
describ
onset
encephalopathi
within
week
onset
jaundic
consider
geograph
variat
etiolog
acut
flf
common
caus
japan
asia
relat
viral
hepat
hepat
e
lead
caus
india
wherea
hepat
b
viru
infect
lead
caus
franc
japan
tempor
chang
etiolog
flf
evid
druginduc
acetaminophen
toxic
fulmin
hepat
failur
current
lead
caus
liver
failur
western
develop
countri
mani
virus
hepat
also
recogn
caus
flf
childhood
includ
epsteinbarr
viru
cytomegaloviru
paramyxoviru
varicellazost
viru
herpesviru
type
parvoviru
adenoviru
hepat
b
viru
common
caus
flf
endem
area
recogn
sourc
infect
includ
women
posit
antihepat
b
antigen
give
birth
carrier
subdetermin
hepat
b
surfac
antigen
donat
blood
hepat
viru
infect
wellknown
caus
flf
individu
age
estim
preval
rate
diagnosi
hepat
viru
infect
made
presenc
antihepat
viru
igm
patient
serum
risk
develop
flf
gener
low
group
higher
risk
pregnant
women
acut
hepat
e
viru
infect
risk
flf
around
mortal
risk
develop
flf
hepat
viru
infect
increas
age
preexist
liver
diseas
fulmin
hepat
b
seen
adult
infect
rel
rare
pathogenesi
flf
usual
initi
exposur
suscept
person
agent
capabl
induc
sever
hepat
injuri
even
though
exact
etiolog
remain
undisclos
case
flf
similarli
pathophysiolog
mechan
involv
occurr
hepat
encephalopathi
children
flf
fulli
defin
viral
agent
may
caus
damag
hepatocyt
either
direct
cytotox
effect
result
hyperimmun
respons
appar
interact
infecti
agent
host
determin
incid
flf
fulmin
hepat
failur
uncommon
devast
ill
liver
fail
short
period
time
week
initi
definit
absenc
chronic
liver
diseas
must
distinguish
much
common
acut
decompens
develop
abruptli
without
warn
patient
chronic
liver
diseas
fulmin
hepat
failur
mortal
rate
higher
signific
morbid
result
cerebr
edema
intracrani
hypertens
rare
patient
chronic
diseas
fulmin
hepat
failur
defin
develop
coagulopathi
encephalopathi
associ
rapid
progress
multipl
organ
system
failur
acetaminophen
surpass
viral
hepat
lead
caus
fulmin
hepat
failur
unit
state
account
perhap
much
case
mortal
rate
high
recoveri
possibl
patient
support
care
decis
proceed
liver
transplant
complic
although
cours
may
protract
recoveri
usual
complet
liver
transplant
remain
sole
lifesav
option
mani
patient
patient
fulmin
hepat
mortal
transfer
immedi
facil
offer
liver
transplant
nevertheless
improv
understand
recognit
syndrom
aggress
medic
therapi
intens
monitor
advent
orthotop
liver
transplant
treatment
option
surviv
rate
improv
consider
flf
constitut
medic
emerg
tendenc
evolv
rapidli
prompt
respons
experienc
clinician
imper
success
outcom
achiev
